AlphAIAlphAI — Financial news for AI agents
Investing.comFEB 194 min read$UAN

Earnings call transcript: CVR Partners LP Q4 2025 reveals revenue miss

CVR Partners LP reported a net loss of $10 million and net sales of $131 million for Q4 2025, missing analyst expectations with an EPS of -$0.80. The company's stock dropped 0.92% premarket due to lower ammonia plant utilization from facility maintenance and startup issues. Despite the setback, CVR Partners remains optimistic about strong fertilizer demand for the upcoming planting season and plans operational improvements for Q1 2026.

Original reporting
Investing.com · Investing.com Transcripts
Published Feb 19, 2026, 4:58 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Feb 19, 2026, 6:00 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefFinancial news
Primary signal
$UAN
Bearish
medium confidence
Mentioned
$UAN
Relevance
6/10
AlphAI data visualization · based on Investing.com
Decision brief

The 30-second read

$UANBearishMed
01

Why it matters

Operational setbacks led to stock decline; however, industry demand remains strong, suggesting a potential rebound after operational improvements.

02

Market read

The news primarily affects fertilizer industry stocks, especially CVR Partners LP and related companies, with limited broader market impact.

03

What to watch

Potential for industry-wide supply chain improvements and favorable fertilizer prices in upcoming seasons could offset short-term setbacks.

Relevance 6/10Timing: short-term (next 1-2 weeks)

Background

CVR Partners LP reported a revenue miss and net loss in Q4 2025, mainly due to ammonia plant maintenance and startup issues.

Company-level read

Ticker impact

$UANBearishMedium confidence
Context

The news primarily concerns CVR Partners LP, a fertilizer company, and mentions ammonia plant issues affecting its operations.

Expected impact

Potential short-term decline of approximately 2-4% due to earnings miss and operational setbacks.

Evidence & confidence

The earnings miss and operational issues have a direct negative impact, but the company's positive outlook and industry demand could mitigate longer-term downside.

Market effects

Sector

Potential negative sentiment towards fertilizer producers; cautious outlook for related energy and transportation sectors.

Regional

Limited; primarily affecting U.S. fertilizer and energy sectors.

Global

Low; impact mostly confined to North American fertilizer industry.

Counterpoint

What could challenge this read

Operational issues may be temporary, and the company's strong fertilizer demand outlook could lead to a quick recovery, making this a buying opportunity for long-term investors.

Key entities

  • Company
    CVR Partners LP

    A producer of nitrogen fertilizer products.

  • Ticker
    UAN

    UAN is a fertilizer stock with a bearish sentiment indicated by a -0.40 score.

Read at source← All news

Related articles

JUL 29
$UANMed

CVR Partners Reports Second Quarter 2026 Results

CVR PARTNERS, LP (UAN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 CVR Partners Reports Second Quarter 2026 Results • Second quarter net income of $78 million, or $7.33 per common unit; EBITDA of $107 million • Achieved a combined ammonia utilization rate of 99 percent for the second quarter of 2026 • Announced cash distribution of

SEC EDGAR 8-K6 min
OCT 28
$FWRDMed

Forward Air Announces Two-Year Definitive Agreement to Retain Significant Portion of Previously Disclosed Customer Relationship

FORWARD AIR CORP (FWRD) filed an SEC Form 8-K — Other Events. Forward Air Announces Two-Year Definitive Agreement to Retain Significant Portion of Previously Disclosed Customer Relationship 2026 to 2028 Forecasted Annual Revenue from Customer Expected to Exceed 2025 Revenue Driven by Growth in Retained Services DALLAS – October 28, 2026 – F

SEC EDGAR 8-K4 min
OCT 28
$PYPDMedAI 8/10

PolyPid unveils PD01B for diabetic foot infection treatment

PolyPid Ltd. (NASDAQ:PYPD) introduced PD01B, a product candidate for treating moderate to severe diabetic foot infections, using its Kynatrix delivery technology. The company plans to initiate a first-in-human study in the second half of 2027. PolyPid also expects a decision on its lead product D-PLEX₁₀₀ by November 28, 2026, with a potential U.S. launch in early 2027, subject to FDA approval.

investing.com2 min
OCT 28
$KTOSMed

Kratos wins $33.6 million NASA power system contract

Kratos Defense & Security Solutions (KTOS) won a $33.6M contract from NASA to design and build a power system for the Space Reactor-1 Freedom spacecraft, launching in 2028. Kratos will work as a subcontractor to Sierra Lobo under NASA’s SpaceDOC III contract, providing a power conversion system for the mission to Mars. The spacecraft aims to demonstrate nuclear electric propulsion technology. According to the company, the contract is a significant milestone in advancing space nuclear propulsion.

investing.com3 min